Holistic Approach of Siddha Medicine in Treating Polycystic Ovarian Syndrome: A Case Report
Keywords:
Polycystic Ovarian Syndrome, Siddha Medicine, Holistic Treatment, Menstrual Irregularity, Weight Management.Abstract
Background:
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder marked by irregular menstruation, hyperandrogenism, and polycystic ovaries. Conventional treatments often provide limited relief. This case explores the effect of Siddha holistic therapy in a 39-year-old woman with irregular cycles, right ovarian cyst, mild constipation, and weight gain.
Case Presentation:
The patient had a 4-month history of irregular periods, 5 kg weight gain, and neck pigmentation. Ultrasound showed a right ovarian cyst. Lab results were normal, and prior hormone therapy offered minimal relief.
Treatment and Outcome:
The Siddha regimen included initial detoxification with Sukku Thylam oil bath and Aagasthiyar Kolambu purgation, followed by internal medicines like Nandhi Melugu, Kalarchi Tablets, Aadhuthedapalai Thylam, Neermulikudineer, and Manduraadaikasayam for 45 days. A tailored diet and yoga were also advised. Constipation resolved in 2 days; by 3 months, menstrual cycles normalized and weight reduced. After 8 months, fatigue and pigmentation improved significantly.
Conclusion:
Siddha therapy showed promising results in managing PCOS symptoms and improving overall well-being, offering a viable alternative for patients unresponsive to conventional treatment.
References
1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29(2):181–191.
2. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes Relat Metab Disord. 2008;32(7):1035-1041. doi:10.1038/ijo.2008.52
3. Azziz R, Carmina E, Dewailly D, et al. Criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril. 2006;86(5):183-187. doi:10.1016/j.fertnstert.2006.03.007
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. doi:10.1016/j.fertnstert.2003.10.004
5. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. doi:10.1210/jc.2013-2350
6. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367-378. doi:10.1093/humupd/dmn012
7. Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214-221. doi:10.1016/j.cca.2019.11.003
8. Raut LP, Kodur SR, Venugopal B, et al. Effectiveness of Siddha medicine on obesity management: A randomized control trial. J Tradit Complement Med. 2021;11(5):495-501. doi:10.1016/j.jtcme.2021.01.008
